All In MedTech

Company

Unomedical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Unomedical, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

No 5%+ shareholder filings or SBIR grants found under the name Unomedical.

Latest FDA decisions

Search the Clearance Tracker

2 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

No device trials list this company as lead sponsor.

Reports received

198,063

Received Nov 1, 2025 to Nov 20, 2026. Includes 10 of another or unstated type.

Malfunction reports

127,922

65% of reports

Injury reports

69,740

35% of reports

Death reports

391

0.2% of reports

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2315300
Jan 24353700
Feb 2416200
Mar 243500
Apr 2433500
May 241,94010200
Jun 246,04541000
Jul 247,22846200
Aug 245,02048620
Sep 243,42744800
Oct 242,87538800
Nov 242,82647610
Dec 242,42742300
Jan 252,37237400
Feb 252,21536000
Mar 252,38144500
Apr 252,39146210
May 251,96579000
Jun 251,02443500
Jul 2596538000
Aug 2598442100
Sep 2593056500
Oct 2589351910
Nov 251,02072900
Dec 2549825220
Jan 2691836100
Feb 2695154600
Mar 266,1782,19500
Apr 268,4676,36040
May 2610,3636,73240
Jun 2612,4329,8273110
Jul 2618,3629,454113
Aug 2626,50911,637237
Sep 2621,98810,441230
Oct 2620,23611,206130
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

7 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

7 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Z-3186-2024 · Started Jul 23, 2024 · Posted by FDA Sep 19, 2024

    Reason given: Specific VariSoftTM Infusion Sets were packaged using incorrect secondary packaging (boxes) branded "Trusteel Infusion Set".

    Cause as FDA categorized it: Process change control · Device type: Set, Administration, Intravascular (FPA)

  • Z-1544-2024 · Started Mar 5, 2024 · Posted by FDA Apr 15, 2024

    Reason given: Specific lots of Neria Soft Infusion Sets, which have been shipped into the US Market, have been shipped with the incorrect Instruction for Use (IFU) within the final pack. The IFU included is the IFU registered for the Rest of World (ROW) countries. The difference between the US IFU and the ROW IFU is the addition of...

    Cause as FDA categorized it: Device Design · Device type: Set, Administration, Intravascular (FPA)

  • Z-0232-2024 · Started Oct 11, 2023 · Posted by FDA Nov 21, 2023

    Reason given: The Varisoft infusion set is used in conjunction with tandem insulin pumps. The defect reported was damage to the connector piece during manufacturing. This damage results in the connector becoming detached more easily from the insulin set than expected, requiring less force to disconnect than intended. Disconnection,...

    Cause as FDA categorized it: Process change control · Device type: Set, Administration, Intravascular (FPA)

49 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.